Thyroid and parathyroid disease
Conditions
Interventions
pantazocine (15mg)(Group P)
pentazocine(15mg)+hydroxyzine (25mg)(Group PH)
paracetamol (500-1000mg)(Group A)
Sponsors
Ito Hospital Department of Surgery
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: All the patients who consented to participate in this randomized control trial were enrolled.
Exclusion criteria
Exclusion criteria: The patients who had known allergy to pentazocine, hydroxyzine and acetaminophen.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Effectiveness for acute pain | — |
Secondary
| Measure | Time frame |
|---|---|
| Time to first ambulation from bed rest after surgery | — |
Countries
Japan
Contacts
Public ContactTakashi Uruno
Ito Hospital Surgery
Outcome results
None listed